XV Association for Ocular Pharmacology and Therapeutics Meeting (AOPT 2021)

项目摘要 本申请要求提供资金，资助青年科学家出席第十五次双年度会议的差旅费 将于2021年3月4日至7日在迈阿密举行的眼部药理学和治疗学协会（AOPT）会议上举行。这 是一个汇集了正在开发治疗眼疾新方法的科学家的会议。AOPT是一个 全球非营利501（c）3组织，面向眼科相关所有学科的科学家和个人 药理学及其在眼科疾病中的治疗应用。AOPT拥有多元化的多国成员 由临床前和临床科学家、学生和医疗保健专业人员组成。成员来自 学术机构、制药和生物技术行业、设备公司、诊所和私人执业。到 为了实现其使命，学会组织两年一次的会议，并为同行提供编辑领导， 《Journal of Ocular Pharmacology and Therapeutics》杂志。AOPT的使命有三个方面（来自AOPT 网站：www.aopt.org）：⑴作为出版、传播和 交流有关眼科疾病治疗的信息和知识，从基础和临床眼科 药理学和治疗学到相关学科，如药代动力学和动力学，代谢， 转化研究、安全性、药物输送和药剂学;（2）促进研究的进步 （3）协助研究人员和眼科护理专业人员进一步提高他们的 了解眼部疾病的治疗。根据AOPT的使命，R13的具体目标 申请是：（一）提高20名年轻科学家（包括妇女和 （二）提供一个论坛， 传播关于新的治疗方法的最新知识进展， （三）创造一个有利于交流新思想的环境 在基础和临床科学家中，为所有种族的视觉科学家创造机会， 社会背景，以满足和建立研究合作。AOPT-2021的主题是“恢复 通过再生的愿景”，并安排了一些会议，重点是再生 与眼前节和眼后节相关的药物。

Project Summary The present application requests funds to support travel for young scientists to attend the XV Biennial Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) in Miami from March 4th-7th, 2021. This is a conference that brings together scientists who are developing new ways to treat eye diseases. AOPT is a global not-for-profit 501(c)3 organization for scientists and individuals from all disciplines related to ocular pharmacology and its therapeutic applications to eye disease. AOPT has a diverse, multi-national membership composed of preclinical and clinical scientists, students, and healthcare professionals. Members are from academic institutions, pharma and biotech industries, device companies, clinics and private practice. To achieve its mission, the society organizes biennial conferences and provides editorial leadership for the peer- reviewed Journal of Ocular Pharmacology and Therapeutics. The mission of AOPT is threefold (from AOPT website: www.aopt.org): (1) To serve as a global forum and network for the publication, dissemination and exchange of information and knowledge on treatments of eye diseases, from basic and clinical ocular pharmacology and therapeutics to related disciplines such as pharmacokinetics and dynamics, metabolism, translational research, safety, drug delivery, and pharmaceutics; (2)To promote the advancement of research and scientific progress in these fields; (3) To assist researchers and eye-care professionals in furthering their understanding of the treatment of ocular disorders. In line with the AOPT mission, the specific Aims of the R13 application is: (I) To enhance the emerging careers of 20 young scientists (including women and underrepresented minorities) in ocular therapeutics by providing travel awards; (II) To provide a forum for dissemination of the most recent advances in the state of knowledge on novel therapeutic approaches to ocular disorders and disease; (III) To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. The theme of AOPT-2021 is “Restoring vision through Regeneration” and a number of sessions are scheduled which are focused on regenerative medicine related to anterior as well as posterior eye segments.